Skip to main content

Month: May 2020

Havertys Announces Timing of First Quarter 2020 Earnings Release and Investor Conference Call

ATLANTA, May 13, 2020 (GLOBE NEWSWIRE) — HAVERTYS (NYSE: HVT and HVT.A) will release first quarter 2020 financial results on Wednesday, May 20, 2020, after the market closes. The company will host a conference call with investors and analysts on Thursday, May 21, 2020 at 10:00 a.m. (ET) to discuss the results of its operations.Havertys invites interested parties to listen to the live audiocast of the conference call at its website, havertys.com. A replay will be available at the website or via telephone at approximately 1:00 p.m. (ET) through Sunday, May 31, 2020. The number to access the telephone playback is 888-203-1112 (access code: 4738831).About HavertysHavertys (NYSE: HVT and HVT.A), established in 1885, is a full-service home furnishings retailer with 120 showrooms in 16 states in the Southern and Midwestern regions providing...

Continue reading

Liberty Gold Reports Q1 2020 Financial and Operating Results

VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — Liberty Gold Corp. (LGD – TSX) (“Liberty Gold” or the “Company”), is pleased to announce its financial and operating results for the three months ended March 31, 2020. All amounts are presented in United States dollars (“USD”) unless otherwise stated.Liberty Gold is focused on advancing a pipeline of Carlin-Style gold deposits in the Great Basin, U.S.A., a mining-friendly jurisdiction that is home to large-scale oxide gold systems ideal for open-pit heap leach mining. The Great Basin covers portions of the states of Nevada, Utah and Idaho. The Company has a proven track-record in discovery and building value in this region.Recent HighlightsLiberty Gold signed a definitive agreement to sell our interest in the Kinsley Mountain gold deposit1...

Continue reading

Cryptologic Releases 2019 Year End Financial Results

TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — Cryptologic Inc. (“Cryptologic” or the “Company”) (CSE:CRY) today announces its financial results for the year ended December 31, 2019.  Selected financial information of the Company for the three months and years ended December 31, 2019 and 2018 is set forth below:For the Three Months Ended December 31, 2019 and 2018During the three months ended December 31, 2019, the Company mined 300.74 Bitcoins compared to 918.35 Bitcoins in the prior year period. The decrease in Bitcoins results from (i) the sale of 8,475 mining machines representing approximately 38% of the Company’s total miners, and (ii) increased network difficulty due to increased network hashrate and a corresponding decrease in coin production per miner. Average network difficulty for the three months ended December 31, 2019 was...

Continue reading

Genocea to Present Long-term Follow-up Data from GEN-009 Neoantigen Vaccine at Virtual ASCO 2020

Seven out of eight patients treated on Part A of the study are without disease progression at one-year median follow-upATLAS™-identified neoantigens generate broad, sustained T cell responses starting after only 4 weeks and lasting for up to 6 months after the last vaccinationCAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will present updated durability, safety and immunogenicity clinical data from Part A of its ongoing Phase 1/2a trial for GEN-009, the company’s lead neoantigen vaccine candidate at the virtual 2020 American Society for Clinical Oncology (ASCO) Annual Meeting from May 29-31.The analysis evaluates eight patients from Part A of the trial who were vaccinated with GEN-009 as adjuvant therapy,...

Continue reading

First Majestic Initiates NAFTA Arbitration Process Against Mexico for Violating International Law

VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — FIRST MAJESTIC SILVER CORP. (the “Company” or “First Majestic”) announced today that the Mexican tax authority, the Servicio de Administracion Tributaria (“SAT”), has by its various actions exhibited a total disregard for the applicable provisions of three separate double taxation treaties that it has entered into with Canada, Barbados and Luxembourg, which are relevant to First Majestic and its subsidiaries.SAT has repeatedly and unilaterally chosen to reject requests for dispute resolution procedures, known as mutual agreement procedures (“MAPs”), contained within those three treaties designed for addressing differences in interpretation and application of those treaties. According to the Company’s advisors, such action is unprecedented not only for Mexico...

Continue reading

Gold X Announces Increase in Shareholder Support for Merger With Gran Colombia and Guyana Goldfields

VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — Gold X Mining Corp. (“Gold X”) (TSXV: GLDX, OTCQX: SSPXF) is pleased to announce that certain shareholders of Gold X, who collectively hold 2,897,225 shares or 7.62% of Gold X’s issued common shares, have entered into voting support agreements in favour of the business combination (the “Gold X Transaction”) with Gran Colombia Gold Corp. (“Gran Colombia”) (TSX: GCM; OTCQX: TPRFF).When added to the previously announced voting support agreements entered into by directors, officers and shareholders of Gold X, the aggregate number of common shares for which voting support agreements have been signed is 8,785,015 common shares or 23.10% of Gold X’s issued common shares.  As a result, including the common shares held by Gran Colombia, 42.33% of Gold X’s issued common shares will...

Continue reading

Oncocyte Announces New Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting Demonstrating That the DetermaIO™ Gene Expression Test May Predict Response to Immunotherapy in Triple Negative Breast Cancer

Combined with the previously presented data in non-small cell lung cancer (NSCLC), these data expand the potential clinical applicability of DetermaIO™ across cancer typesCollaborators will also present results from a health economic study of DetermaRx™, demonstrating its potential healthcare savings of up to $450 millionIRVINE, Calif., May 13, 2020 (GLOBE NEWSWIRE) — Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced presentations at the 2020 American Society of Clinical Oncology (ASCO), being held virtually May 29-31, 2020.  “Our studies being presented at ASCO highlight Oncocyte’s focus on providing high-value tests to patients across the cancer care continuum,” said Ron Andrews, Chief...

Continue reading

Epsilon Reports First Quarter 2020 Results

HOUSTON, May 13, 2020 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported first quarter 2020 financial and operating results and material subsequent events following the end of the quarter through the date of this release.Marcellus net revenue interest (NRI) gas production averaged 29.4 MMcf/d (Working Interest of 33.8 MM/d). Auburn System gathered and delivered 23 Bcfe gross (8.1 Bcfe net to Epsilon’s interest) which represents approximately 77% of the designed throughput capacity.  Total Revenues of $6.4 MM for the quarter Generated EBITDA of $4.6 MM and free cash flow (FCF) of $2.9 MM for the quarter. Net income before tax of $0.64 MM for the quarter following a $1.76 MM write down of the Oklahoma producing assets resulting from the recent drastic price deterioration due to global...

Continue reading

Macarthur engages North American investor relations group

VANCOUVER, British Columbia, May 13, 2020 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (TSX-V: MMS) (ASX: MIO) (the “Company” or “Macarthur”) has engaged Canadian company Investor Cubed Inc. (”Investor Cubed”) to provide capital markets advice, investor relations and marketing development services to the Company.The engagement terms with Investor Cubed are:a consulting contract paying C$5,000 per month for a term of twelve months; andRight to purchase 1,500,000 options for Macarthur shares, granted as follows: 500,000 options with an exercise price of C$0.16 exercisable until 31 December 2022 500,000 options with an exercise price of C$0.24 exercisable until 31 December 2022 500,000 options with an exercise price of C$0.32 exercisable until 31 December 2022.The performance based options will be governed by the provisions of Macarthur’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.